Aeolus Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $2.06 per share
Published in Lab Business Week, January 30th, 2005
The company reported a net loss attributable to common stockholders of $17,302,000, or $2.06 per share. For the previous fiscal year ended September 30, 2003, the company had a net loss attributable to common stockholders of $3,925,000, or $2.88 per share.
For the quarter ended September 30, 2004, Aeolus had a net loss attributable to common stockholders of $2,048,000 or $.15 per share. For the quarter ended September 30, 2003, Aeolus had a net loss attributable to common stockholders of $1,315,000, or $.96 per share.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-01-30)
More Articles from Lab Business Week
- Affymetrix, Inc.
Genelabs gets $1.25M for amendment to DNA amplification technology license - AngioDynamics, Inc.
Device firm reports second quarter EPS up 50% to $0.09 - Aradigm Corporation
Pharmaceutical firm announces $12.5M private placement financing - Arrowhead Research Corporation
Nanotech company named to Merrill Lynch index - Avanir Pharmaceuticals
Pharmaceutical firm reports loss of $0.09 per share - Avitar, Inc.
Diagnostics company reports loss of $0.12 per share - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
